ES2325254T3 - Metodo para la preparacion de un acido silicico que comprende material extruido, dicho material extruido, su uso y una composicion farmaceutica que comprende dicho material extruido. - Google Patents
Metodo para la preparacion de un acido silicico que comprende material extruido, dicho material extruido, su uso y una composicion farmaceutica que comprende dicho material extruido. Download PDFInfo
- Publication number
- ES2325254T3 ES2325254T3 ES03787792T ES03787792T ES2325254T3 ES 2325254 T3 ES2325254 T3 ES 2325254T3 ES 03787792 T ES03787792 T ES 03787792T ES 03787792 T ES03787792 T ES 03787792T ES 2325254 T3 ES2325254 T3 ES 2325254T3
- Authority
- ES
- Spain
- Prior art keywords
- extruded material
- silicic acid
- extrudate
- acid
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000012239 silicon dioxide Nutrition 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000463 material Substances 0.000 title 3
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 title 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 abstract 5
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 210000002808 connective tissue Anatomy 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 239000006052 feed supplement Substances 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 abstract 1
- 150000003377 silicon compounds Chemical class 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/28—Silicates, e.g. perlites, zeolites or bentonites
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/20—Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/25—Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Animal Husbandry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
Abstract
Método para la preparación de un producto extruido que comprende ácido silícico, que comprende los pasos de: i) formación de ácido silícico estabilizado, por hidrólisis de un compuesto de silicio en ácido ortosilícico y/u oligómeros del mismo en presencia de un agente estabilizador, que es un compuesto de amonio cuaternario, o un aminoácido, o una fuente de aminoácido o combinaciones de los mismos; ii) mezcla del ácido silícico estabilizado con un vehículo en una cantidad hasta la capacidad de carga de ácido silícico en el vehículo; y iii) extrusión de la mezcla resultante formando con ello el producto extruido.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02078336A EP1391426A1 (en) | 2002-08-12 | 2002-08-12 | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2325254T3 true ES2325254T3 (es) | 2009-08-31 |
Family
ID=30775855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES03787792T Expired - Lifetime ES2325254T3 (es) | 2002-08-12 | 2003-08-12 | Metodo para la preparacion de un acido silicico que comprende material extruido, dicho material extruido, su uso y una composicion farmaceutica que comprende dicho material extruido. |
Country Status (15)
Country | Link |
---|---|
US (2) | US8771757B2 (es) |
EP (2) | EP1391426A1 (es) |
JP (2) | JP4727227B2 (es) |
CN (2) | CN1678524A (es) |
AT (1) | ATE428404T1 (es) |
AU (1) | AU2003266283B2 (es) |
CA (1) | CA2494165C (es) |
CY (1) | CY1109228T1 (es) |
DE (1) | DE60327231D1 (es) |
DK (1) | DK1551763T3 (es) |
ES (1) | ES2325254T3 (es) |
IL (2) | IL166779A0 (es) |
PT (1) | PT1551763E (es) |
SI (1) | SI1551763T1 (es) |
WO (1) | WO2004016551A1 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1391426A1 (en) | 2002-08-12 | 2004-02-25 | Bio Minerals N.V. | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
ITMI20050093A1 (it) * | 2005-01-25 | 2006-07-26 | Unimer Spa | Procedimento industriale per ottenere la granulazione di fertilizzanti mangimi e altri prodotti a partire da un procedimento preliminare di pellettatura |
US7700083B2 (en) * | 2005-10-24 | 2010-04-20 | Kevin Meehan | Skin care composition for accelerated production of collagen proteins and method of fabricating same |
FR2909558B1 (fr) * | 2006-12-12 | 2009-04-17 | Ceva Sante Animale Sa | Procede de fabrication de premelanges medicamenteux |
WO2009052090A2 (en) * | 2007-10-15 | 2009-04-23 | 7 Oaks Pharmaceutical Corporation | Silicate containing compositions and methods of treatment |
GB0720423D0 (en) * | 2007-10-19 | 2007-11-28 | Univ Leuven Kath | Method for brewing beer |
GB0805279D0 (en) * | 2008-03-20 | 2008-04-30 | Univ Nottingham Trent | Food supplement |
WO2009127256A1 (en) * | 2008-04-17 | 2009-10-22 | Jisbrey, S.A | Hydronium stabilized and dissoluble silicic acid nanoparticles: preparation, stabilization and use |
CZ2008841A3 (cs) * | 2008-12-23 | 2010-07-28 | Agra Group, A.S. | Pivo a nápoje na bázi piva a zpusob úpravy obsahu polyfenolu a kremíku v nich |
GB0913255D0 (en) | 2009-07-30 | 2009-09-02 | Sisaf Ltd | Topical composition |
DE102010008982A1 (de) | 2010-02-24 | 2011-08-25 | Bayer Innovation GmbH, 40225 | Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie |
DE102010008981A1 (de) * | 2010-02-24 | 2011-08-25 | Bayer Innovation GmbH, 40225 | Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie |
WO2012032364A1 (en) | 2010-09-06 | 2012-03-15 | Creogen D.O.O. | Stabilized solution of ortho-silicic acid based on salicylic acid as effective inhibitor of its polymerization, its preparation and use |
WO2012035364A1 (en) | 2010-09-15 | 2012-03-22 | Creogen D.O.O. | Stabilized solution of ortho-silicic acid, its preparation and use |
US10986647B2 (en) * | 2017-05-04 | 2021-04-20 | At&T Intellectual Property I, L.P. | Management of group common downlink control channels in a wireless communications system |
CN107988292B (zh) * | 2018-01-18 | 2023-12-26 | 江苏江山聚源生物技术有限公司 | 提高重组人源胶原蛋白稳定性的发酵工艺 |
EP3549578A1 (en) | 2018-04-06 | 2019-10-09 | Bio Minerals N.V. | Silicic acid formulation and use thereof |
EP3632449A1 (en) * | 2018-10-05 | 2020-04-08 | Bio Minerals N.V. | Silicic acids for use in the treatment of periodontitis |
EP3650011A1 (en) * | 2018-11-09 | 2020-05-13 | Bio Minerals NV | Water soluble silicon-containing granulate |
PL3662761T3 (pl) * | 2018-12-04 | 2021-11-02 | Dsm Ip Assets B.V. | Stabilne podczas przechowywania adsorbaty związków nitrooksy |
GB201904336D0 (en) | 2019-03-28 | 2019-05-15 | Sisaf Ltd | A delivery system |
CA3142991A1 (fr) | 2019-06-28 | 2020-12-30 | Tilman | Composition comprenant un extrudat thermoforme d'au moins un triterpene et/ou au moins une de leurs formes glycosylees |
GB202104173D0 (en) * | 2021-03-24 | 2021-05-05 | Ab Vista | Animal feed composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL9400189A (nl) | 1994-02-07 | 1995-09-01 | Bio Pharma Sciences Bv | Gestabiliseerd orthosiliciumzuur bevattend preparaat, een werkwijze voor het bereiden daarvan en een biologisch preparaat. |
FR2799758B1 (fr) * | 1999-10-15 | 2002-05-17 | Exsymol Sa | Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation |
EP1110909A1 (en) * | 1999-12-24 | 2001-06-27 | Bio Minerals N.V. | Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use |
EP1391426A1 (en) | 2002-08-12 | 2004-02-25 | Bio Minerals N.V. | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
-
2002
- 2002-08-12 EP EP02078336A patent/EP1391426A1/en not_active Withdrawn
-
2003
- 2003-08-12 PT PT03787792T patent/PT1551763E/pt unknown
- 2003-08-12 CN CNA03820875XA patent/CN1678524A/zh active Pending
- 2003-08-12 CA CA002494165A patent/CA2494165C/en not_active Expired - Lifetime
- 2003-08-12 US US10/524,189 patent/US8771757B2/en active Active
- 2003-08-12 DE DE60327231T patent/DE60327231D1/de not_active Expired - Lifetime
- 2003-08-12 CN CN201010144554A patent/CN101829143A/zh active Pending
- 2003-08-12 DK DK03787792T patent/DK1551763T3/da active
- 2003-08-12 AU AU2003266283A patent/AU2003266283B2/en not_active Expired
- 2003-08-12 EP EP03787792A patent/EP1551763B1/en not_active Expired - Lifetime
- 2003-08-12 WO PCT/EP2003/009009 patent/WO2004016551A1/en active Application Filing
- 2003-08-12 SI SI200331616T patent/SI1551763T1/sl unknown
- 2003-08-12 JP JP2004528493A patent/JP4727227B2/ja not_active Expired - Lifetime
- 2003-08-12 IL IL16677903A patent/IL166779A0/xx unknown
- 2003-08-12 AT AT03787792T patent/ATE428404T1/de active
- 2003-08-12 ES ES03787792T patent/ES2325254T3/es not_active Expired - Lifetime
-
2005
- 2005-02-09 IL IL166779A patent/IL166779A/en active IP Right Grant
-
2009
- 2009-07-14 CY CY20091100732T patent/CY1109228T1/el unknown
-
2010
- 2010-08-06 JP JP2010178022A patent/JP2010265309A/ja active Pending
-
2014
- 2014-05-19 US US14/281,258 patent/US8945617B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IL166779A0 (en) | 2006-01-15 |
EP1551763B1 (en) | 2009-04-15 |
DE60327231D1 (de) | 2009-05-28 |
JP2010265309A (ja) | 2010-11-25 |
US8771757B2 (en) | 2014-07-08 |
US20140255493A1 (en) | 2014-09-11 |
SI1551763T1 (sl) | 2009-10-31 |
CN1678524A (zh) | 2005-10-05 |
DK1551763T3 (da) | 2009-07-20 |
US20060099276A1 (en) | 2006-05-11 |
CA2494165C (en) | 2009-05-26 |
ATE428404T1 (de) | 2009-05-15 |
WO2004016551A1 (en) | 2004-02-26 |
JP2005535549A (ja) | 2005-11-24 |
US8945617B2 (en) | 2015-02-03 |
EP1391426A1 (en) | 2004-02-25 |
CA2494165A1 (en) | 2004-02-26 |
PT1551763E (pt) | 2009-07-07 |
CY1109228T1 (el) | 2014-07-02 |
JP4727227B2 (ja) | 2011-07-20 |
IL166779A (en) | 2010-05-17 |
AU2003266283B2 (en) | 2008-04-10 |
EP1551763A1 (en) | 2005-07-13 |
AU2003266283A1 (en) | 2004-03-03 |
CN101829143A (zh) | 2010-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2325254T3 (es) | Metodo para la preparacion de un acido silicico que comprende material extruido, dicho material extruido, su uso y una composicion farmaceutica que comprende dicho material extruido. | |
PT1226267E (pt) | Processo para produzir um produto tripeptidos anti-hipertensores | |
CL2003002767A1 (es) | Composicion oral que comprende una pelicula que contiene un material funcional, en un vehiculo, util para el cuidado oral. | |
JP2006117700A5 (es) | ||
EP0922395A4 (en) | PRODUCT COMPRISING A HEALTH-FRIENDLY INGREDIENT AND PROCESS FOR PRODUCING THE SAME | |
CA2027483A1 (fr) | Procede de preparation d'une solution aqueuse effervescente ayant une action emolliente sur la cuticule des ongles, composition pour la mise en oeuvre dudit procede et traitement cosmetique correspondant | |
DE50306384D1 (de) | Mikro-emulsionen mit binärer phasen- und wirkstoffdifferenzierbarkeit, deren herstellung und deren verwendung, insbesondere zur topischen sauerstoffversorgung | |
DE50004018D1 (de) | Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen | |
CY1110600T1 (el) | Αναλογα της βιταμινης d | |
EA200601191A1 (ru) | Продукты для ухода за ранами, содержащие кератин | |
EA200501069A1 (ru) | Состав для местного применения и способы обработки старческой или повреждённой воздействием окружающей среды кожи | |
ECSP044961A (es) | Acido n-(5-clorosaliciloil)-8-aminocaprilico como agente de suministro oral para fragmentos de hormona paratiroides | |
TWI347846B (es) | ||
WO2004046096A3 (en) | Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics | |
JP2002363035A (ja) | 育毛剤 | |
KR101400971B1 (ko) | 실크 단백질의 가수 분해물을 함유하는 모발 성장 촉진용 화장료 조성물 | |
RU2015153242A (ru) | Действующее вещество для лечения саркопении | |
WO2005037772A3 (fr) | NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE | |
PE20050285A1 (es) | Composicion farmaceutica que comprende analogos ciclicos de somatostatina | |
WO2003101945A8 (en) | Ligands that are inhibitors of the rar receptors | |
AR039908A1 (es) | Composiciones cosmeticas que contienen sales de acido malonico | |
JP2006028240A (ja) | 人造軽石 | |
JP2004168746A (ja) | シルクアミノ酸ジェル | |
ES2143442A1 (es) | Aplicacion del levamisol en la fabricacion de productos dieteticos promotores del crecimiento para peces. | |
BR9704418A (pt) | Processo para estabilização de ácido ascórbico levógiro (laa) composição aquosa estável de laa processo para preparação de uma solução tópica estável de laa e método para tratamento cosmético farmacêutico ou nutricional |